Ixaltis raises $8.9 mln

Ixaltis said May 31 that it raised 8 million euros ($8.9 million) in funding. Investors include Irdinov, Ix o Private Equity, Principia and Sofimac as well as Pierre Olivier Goineau, current President of France Biotech. Paris-based Ixaltis is a biopharmaceutical research and clinical development, specializing in genito-urinary diseases.

Source: Ixaltis website